Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases
Condition(s):Metastatic Cancer; Prostate CancerLast Updated:July 6, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Cancer; Prostate CancerLast Updated:July 6, 2018Terminated
Condition(s):Moderate to Severe Secondary Hyperparathyroidism; Stage 5 Chronic Kidney DiseasesLast Updated:July 30, 2021Completed
Condition(s):Chronic Kidney DiseaseLast Updated:January 25, 2012Completed
Condition(s):Chronic Kidney Disease; Secondary HyperparathyroidismLast Updated:August 1, 2014Completed
Condition(s):Secondary Hyperparathyroidism; End Stage Renal DiseaseLast Updated:August 2, 2006Completed
Condition(s):Chronic Kidney Disease, Stage 5; Secondary HyperparathyroidismLast Updated:December 24, 2009Completed
Condition(s):CKD Stage 3/4Last Updated:August 17, 2020Completed
Condition(s):Pancreatic Ductal AdenocarcinomaLast Updated:June 26, 2023Recruiting
Condition(s):Kidney DiseaseLast Updated:January 19, 2011Completed
Condition(s):End-Stage Kidney DiseaseLast Updated:August 2, 2006Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.